Genomic Risk in Retroperitoneal Sarcoma

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

August 1, 2027

Conditions
Retroperitoneal LiposarcomaSoft Tissue Sarcoma
Interventions
OTHER

Biospecimen sample collection during standard-of-care surgery

Patients in this observational study are undergoing planned surgical resection of their retroperitoneal sarcoma as prescribed by their primary surgeon and treatment team. In addition to removal of the primary tumor, surgeons remove 4 samples of retroperitoneal fat and a sample of subcutaneous fat for further study at the time of the operation.

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER